All the Buzz

All the buzz around the blogshpere & newswires today is about president Obama lifting the ban on embryonic stem cell research.  I have ranted on about this enough already.  To sum it up, it’s a wonderful thing.  I especially like Obama stating that he is going to let Science dictate the path of medical research and not politics.  We’ll see how well he does with that.

Certainly FredCoBio companies like LifeLine, Life Tech and Lonza stand to launch new products and get renewed interest in existing products.  The big issue with the Bush Doctrine was one of perception that there is something illegal about stem cell research.  LifeLine/ISCO is hosting a webinar on March 12th to discuss, if anyone is interested.

Since Frederick county is the Stem Cell captial of thw e world, it’s got to be good for us, right?  According the Stemcelldigest.net ISCO/LifeLine is one of the top performing stem cell companies, in terms of market capitalization change YTD.  I hope that trend continues.  Now Lonza and Life Tech don’t get a lot of attention from the “core” stem cell guys since they’re both involved in a lot of other stuff and not “exclusively” stem cell companies.

According to a recent report from Life Science Intelligence, the regenerative medicine and stem cell fields is expected to grow 16% annually to go from $1.5BB in 2008 to $118BB in 2013.

Riding on the waves of growth, maybe someone can find a job for my old buddy (I should say “long time”) Jim Spencer.  Apparently he fell victim to Life Tech paring back in other groups, perhaps to focus on the growth in stem cell markets?